Adverse effect of unsp fibrinolysis-affecting drugs, init

This code signifies an undesirable or harmful reaction experienced by a patient due to a drug intended to modify fibrinolysis, where the specific drug involved is not documented. Fibrinolysis-affecting drugs include agents that promote clot breakdown (e.g., thrombolytics) or inhibit it (e.g., antifibrinolytics). The "initial encounter" designation indicates that the patient is receiving active treatment for the adverse effect.

Apply this code when a patient presents with symptoms or conditions directly attributable to an adverse reaction from an unidentifiable fibrinolysis-affecting medication. This is appropriate for the first time the patient is seen for this specific adverse event. Use it when the medical record clearly states an adverse effect but lacks the precise drug name.

• Always sequence this code first, followed by codes for the specific manifestations of the adverse effect.
• Avoid using this code if the specific fibrinolysis-affecting drug is known; instead, use the more specific code for that drug.
• Ensure documentation supports an "adverse effect" (properly prescribed and administered) rather than poisoning (incorrect dosage or substance).